BioSpace News Archive

CANTEL MEDICAL CORP. will release the results for its fourth quarter ended July 31, 2020 on Thursday, September 17, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.

Phosplatin Therapeutics announced that new clinical data from a dose escalation study of lead candidate PT-112, an immunogenic cell death inducer, used in combination with PD-L1 checkpoint inhibitor avelumab, will be presented at the upcoming European Society for Medical Oncology Virtual Congress 2020 taking place September 19-21.

Ionis Pharmaceuticals, Inc., the leader in antisense therapeutics, announced that management will present a company overview at the following virtual investor conferences

AVEO Oncology announced that Michael Bailey, president and chief executive officer of AVEO, will participate in two upcoming virtual investor conferences

Ocular Therapeutix, Inc. a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced that it will present and host investor meetings at the following conferences:.

Rallybio, a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders, announced that it has appointed Helen M. Boudreau, former Chief Operating Officer of the Bill & Melinda Gates Medical Research Institute, to its Board of Directors.

Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in three upcoming virtual conferences in September:

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it will be

-- 1 in 9 men will be diagnosed with prostate cancer in their lifetime -- -- Prostate cancer awareness month calls attention to need for research and testing -- [03-September-2020] SAN FRANCISCO , Sept. 3, 2020 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced enrollment has begun for a nationwide stu

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, Steven Lo, will present a company overview at the H.C. Wainwright 22 nd Annual Global Investment Conference on Monday, September 14, 2020 at 1:30 pm ET. A live webcast of the event will be available on the company’s website at http://ir.zosanopharma.com/events-presentations . The archived w